Role of mitochondrial DNA variants and copy number in diabetic atherogenesis

Genetics and Molecular Research

Volumn 11, Issue 3, 2012, Pages 3339-3348

  Chien, M C ^a   Huang, W T ^a   Wang, P W ^a   Liou, C W ^a   Lin, T K ^a   Hsieh, C J ^a   Weng, S W ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Atherosclerosis; Mitochondrial DNA; Type 2 diabetes mellitus

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIBOSOME RNA;

ADULT; ARTERY OCCLUSION; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENETIC CONSERVATION; HETEROPLASMY; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84930485260     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.September.17.4     Document Type: Article

References (24)

1. Allen JF and Raven JA (1996). Free-radical-induced mutation vs redox regulation: costs and benefts of genes in organelles. J. Mol. Evol. 42: 482-492.
2. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, et al. (1981). Sequence and organization of the human mitochondrial genome. Nature 290: 457-465.
3. Brownlee M (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
4. Chappey O, Dosquet C, Wautier MP and Wautier JL (1997). Advanced glycation end products, oxidant stress and vascular lesions. Eur. J. Clin. Invest. 27: 97-108.
5. Croteau DL and Bohr VA (1997). Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J. Biol. Chem. 272: 25409-25412.
6. Du X, Matsumura T, Edelstein D, Rossetti L, et al. (2003). Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112: 1049-1057.
7. Gutierrez J, Ballinger SW, Darley-Usmar VM and Landar A (2006). Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ. Res. 99: 924-932.
8. Lee HC, Yin PH, Lu CY, Chi CW, et al. (2000). Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 348: 425-432.
9. Lee HC, Yin PH, Chi CW and Wei YH (2002). Increase in mitochondrial mass in human fbroblasts under oxidative stress and during replicative cell senescence. J. Biomed. Sci. 9: 517-526.
10. Lu J, Li Z, Zhu Y, Yang A, et al. (2010). Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss. Mitochondrion 10: 380-390.
11. Madamanchi NR and Runge MS (2007). Mitochondrial dysfunction in atherosclerosis. Circ. Res. 100: 460-473.
12. Mercer JR, Cheng KK, Figg N, Gorenne I, et al. (2010). DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ. Res. 107: 1021-1031.
13. Morino K, Petersen KF, Dufour S, Befroy D, et al. (2005). Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115: 3587-3593.
14. Nishikawa T, Edelstein D, Du XL, Yamagishi S, et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790.
15. Petersen KF, Dufour S, Befroy D, Garcia R, et al. (2004). Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350: 664-671.
16. Puddu P, Puddu GM, Galletti L, Cravero E, et al. (2005). Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis. Cardiology 103: 137-141.
17. Rosen P, Nawroth PP, King G, Moller W, et al. (2001). The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 17: 189-212.
18. Ross R (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
19. Sawano T, Tanaka M, Ohno K, Yoneda M, et al. (1996). Mitochondrial DNA mutations associated with the 11778 mutation in Leber's disease. Biochem. Mol. Biol. Int. 38: 693-700.
20. Seneca S, Lissens W, Liebaers I, van den Bergh P, et al. (1998). Pitfalls in the diagnosis of mtDNA mutations. J. Med. Genet. 35: 963-964.
21. Shtilbans A, El-Schahawi M, Malkin E, Shanske S, et al. (1999). A novel mutation in the mitochondrial DNA transfer ribonucleic acidAsp gene in a child with myoclonic epilepsy and psychomotor regression. J. Child Neurol. 14: 610-613.
22. Tanaka N, Goto Y, Akanuma J, Kato M, et al. (2010). Mitochondrial DNA variants in a Japanese population of patients with Alzheimer's disease. Mitochondrion 10: 32-37.
23. Tuppen HA, Fattori F, Carrozzo R, Zeviani M, et al. (2008). Further pitfalls in the diagnosis of mtDNA mutations: homoplasmic mt-tRNA mutations. J. Med. Genet. 45: 55-61.
24. Wong LJ (2007). Pathogenic mitochondrial DNA mutations in protein-coding genes. Muscle Nerve 36: 279-293.